Status:
COMPLETED
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
Lead Sponsor:
University of Freiburg
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-120 years
Brief Summary
This study sought to investigate safety and efficacy of biolimus-eluting stents (BES) with biodegradable polymer as compared with everolimus-eluting stents (EES) with durable polymer through 3 years o...
Detailed Description
A group of 814 consecutive patients undergoing percutaneous coronary intervention (PCI) was enrolled between 2007 and 2010, of which 527 were treated with EES and 287 with BES implantation. Clinical o...
Eligibility Criteria
Inclusion
- all patients with at least one BES or EES for de novo stenosis
Exclusion
- patients with at least one non-study stent
- patients with both study stent
- patients with life expectancy \< 3 years
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
814 Patients enrolled
Trial Details
Trial ID
NCT01472705
Start Date
November 1 2010
End Date
November 1 2011
Last Update
December 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology, university Fribourg Medical Center
Fribourg, Canton of Fribourg, Switzerland, 1708